BioCryst Pharmaceuticals(BCRX) - 2025 Q4 - Earnings Call Transcript

BioCryst Pharmaceuticals (NasdaqGS:BCRX) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsBabar Ghias - Chief Financial Officer and Head of Corporate DevelopmentBill Sheridan - Chief Development OfficerBrian Abrahams - Managing DirectorCharlie Gayer - President and CEOLaura Chico - Managing Director, Equity ResearchMikaela Vanik - Research AssociateNick Wilder - Manager, Investor RelationsConference Call ParticipantsNone - AnalystNone - AnalystNone - AnalystNone - AnalystOperatorWelco ...